Publisher Correction: An engineered ScCas9 with broad PAM range and high specificity and activity

Nat Biotechnol. 2020 Oct;38(10):1212. doi: 10.1038/s41587-020-0604-2.

Authors

Pranam Chatterjee^#^{1

2}, Noah Jakimo^#^{3

4}, Jooyoung Lee⁵, Nadia Amrani⁵, Tomás Rodríguez⁵, Sabrina R T Koseki^{3

4}, Emma Tysinger^{3

4}, Rui Qing⁴, Shilei Hao⁴, Erik J Sontheimer⁵, Joseph Jacobson^{3

4}

Affiliations

¹ MIT Center for Bits and Atoms, Massachusetts Institute of Technology, Cambridge, MA, USA. pranam@mit.edu.
² MIT Media Lab, Massachusetts Institute of Technology, Cambridge, MA, USA. pranam@mit.edu.
³ MIT Center for Bits and Atoms, Massachusetts Institute of Technology, Cambridge, MA, USA.
⁴ MIT Media Lab, Massachusetts Institute of Technology, Cambridge, MA, USA.
⁵ RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA.

^# Contributed equally.

PMID: 32561876
DOI: 10.1038/s41587-020-0604-2

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Publication types

Published Erratum

Grants and funding

GM115911/U.S. Department of Health & Human Services | National Institutes of Health (NIH)